MSDS   | : | Antipyrine, 4-(isopropylamino)-
| CAS   | : | 3615-24-5 | SYNONYMS   | : | * Isopirina
* Isopropylaminoantipyrine
* 4-(Isopropylamino)antipyrine
* 4-Isopropylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
* Isopropylaminophenazon
* Isopropylaminophenazone
* 4-Isopropylamino-1-phenyl-2,3-dimethyl-3-pyrazolin-5-one
* Isopyrin
* Isopyrine
* 4-Monoisopropylamino-1-phenyl-2,3-dimethyl-5-pyrazolone
* 1-Phenyl-2,3-dimethyl-4-(isopropylamino)-2-pyrazolin-5-one
* 1-Phenyl-2,3-dimethyl-4-isopropylaminopyrazolone
* 3H-Pyrazol-3-one,
1,2-dihydro-1,5-dimethyl-4-((1-methylethyl)amino)-2-phenyl-
* Ramifenazone
* Tomanol-wirkstoff
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : CD2975000
CHEMICAL NAME : Antipyrine, 4-(isopropylamino)-
CAS REGISTRY NUMBER : 3615-24-5
BEILSTEIN REFERENCE NO. : 0231936
REFERENCE : 5-25-14-00123 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 7
MOLECULAR FORMULA : C14-H19-N3-O
MOLECULAR WEIGHT : 245.36
WISWESSER LINE NOTATION : T5NNVJ A1 BR& DMY1&1 E1
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Isopirina
* Isopropylaminoantipyrine
* 4-(Isopropylamino)antipyrine
* 4-Isopropylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
* Isopropylaminophenazon
* Isopropylaminophenazone
* 4-Isopropylamino-1-phenyl-2,3-dimethyl-3-pyrazolin-5-one
* Isopyrin
* Isopyrine
* 4-Monoisopropylamino-1-phenyl-2,3-dimethyl-5-pyrazolone
* 1-Phenyl-2,3-dimethyl-4-(isopropylamino)-2-pyrazolin-5-one
* 1-Phenyl-2,3-dimethyl-4-isopropylaminopyrazolone
* 3H-Pyrazol-3-one,
1,2-dihydro-1,5-dimethyl-4-((1-methylethyl)amino)-2-phenyl-
* Ramifenazone
* Tomanol-wirkstoff
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 715 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,1024,1970
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 450 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 10,665,1960
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 820 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 10,665,1960
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1070 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,1024,1970
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 690 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 10,665,1960
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und
Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher
information, see NSAPCC. Volume(issue)/page/year: 233,365,1958
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE/DURATION : 567 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,1024,1970
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Antineoplaston A5
| 142191-84-2 |
Antineoplaston AS2-1
| 104624-98-8 |
Antineoplaston AS2-5
| 104771-87-1 |
Antibiotic SF 1306A
| 52934-70-0 |
Antiogoside
| 3981-17-7 |
Antioside
| 3981-16-6 |
Antioxidant G-15
| 3981-16-6 |
Antioxidant G-16
| 61373-87-3 |
Antioxidant KSM
| 52622-55-6 |
Antioxidant TSP
| 12789-66-1 |
Antiphlei factor-ISUBSTANCE DEFINITION :Isolated from Streptomyces aureusREFERENCE :85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., BocaRaton, FL, CRC Press, 1980- Volume(issue)/page/year: 1,407,1980
| 12789-66-1 |
Antipyrine
| 60-80-0 |
Antipyrine, 4-(beta-acetylstyryl)-
| 24428-81-7 |
Antipyrine, 4-allyl-
| 24428-81-7 |
Antibiotic SF-1670-A
| 60440-43-9 |
Antipyrine, 4-amino-
| 83-07-8 |
Antipyrine, 4-(2-(p-aminobenzoyl)ethyl)-
| 24428-98-6 |
Antipyrine, 4-amino-, and sodium nitrite
| 24428-98-6 |
Antipyrine, 4-(2-(p-anisoyl)vinyl)-
| 24428-77-1 |
Antipyrine, 4,4'-azodi-
| 102585-65-9 |
Antipyrine, 4-(2-benzoylpropenyl)-
| 24428-80-6 |
Antipyrine, 4-(2-benzoylvinyl)-
| 15183-03-6 |
Antipyrine, 4-butyl-
| 101496-03-1 |
Antipyrine, 4-sec-butyl-
| 96974-48-0 |
Antipyrine, compd. with chloral hydrate (12)
| 480-30-8 |
Antibiotic SF 2107 A(sub 1)
| 81030-78-6 |
Antipyrine, 4-(2-(p-chlorobenzoyl)vinyl)-
| 24429-12-7 |
Antipyrine, 4-((p-chlorophenacylidene)amino)-
| 24377-61-5 |
Antipyrine, 4-(2-(diethylamino)ethyl)-
| 24377-61-5 |
Antipyrine,4-((3,4-dimethoxy-2-(1-pyrrolidinylcarbonyl)benzylidene)amino)-
| 66913-52-8 |
Antipyrine, 4-(dimethylamino)-
| 58-15-1 |
Antipyrine, 4-(dimethylamino)- mixed with sodiumnitrite (1:1)
| 58-15-1 |
Antipyrine, 4-(dimethylamino)-, sodium salt
| 6062-19-7 |
Antipyrine, 4-(2,6-dimethylpiperidinothiocarbamoyl)-
| 73791-34-1 |
Antipyrine, 4-ethyl-
| 73791-34-1 |
Antipyrine, 4-(ethylamino)-
| 15166-10-6 |
Antibiotic SF 1306B
| 52934-72-2 |
Antipyrine, 4-(2-(p-hydroxybenzoyl)propenyl)-,hydrate
| 26405-20-9 |
Antipyrine, 4-isobutyl-
| 26405-20-9 |
Antipyrine, 4-isopentyl-
| 26405-20-9 |
Antipyrine, 4-isopropyl-
| 479-92-5 |
Antipyrine, 4-(isopropylamino)-
| 3615-24-5 |
Antipyrine, 4-((m-methoxybenzylidene)amino)-
| 70318-54-6 |
Antipyrine, 4-((p-methoxybenzylidene)amino)-
| 32061-14-6 |
Antipyrine, 4-((p-methoxyphenacylidene)amino)-
| 24428-97-5 |
Antipyrine, 4-(methylamino)-
| 519-98-2 |
Antipyrine, 4-((p-methylphenacylidene)amino)-
| 24428-96-4 |
Antibiotic SF 1771B
| 63798-93-6 |
Antipyrine,4-(4-(3-methyl-2-phenylmorpholino)methyl)-, gentisate
| 63798-93-6 |
Antipyrine,4-(4-(3-methyl-2-phenylmorpholino)methyl)-,hydrochloride
| 50321-35-2 |
|
|